Takeda Pharmaceutical
310 hedge funds and large institutions have $1.76B invested in Takeda Pharmaceutical in 2020 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 86 increasing their positions, 101 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
310
Holders Change
-27
Holders Change %
-8.01%
% of All Funds
6.85%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.18%
New
37
Increased
86
Reduced
101
Closed
59
Calls
$46.4M
Puts
$54.9M
Net Calls
-$8.56M
Net Calls Change
-$10.9M
Top Buyers
| 1 |
LP
LMR Partners
London,
United Kingdom
|
+$26.8M |
| 2 |
Renaissance Technologies
New York
|
+$26.6M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.1M |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$20.1M |
| 5 |
Morgan Stanley
New York
|
+$12.8M |
Top Sellers
| 1 |
GCM
Glenview Capital Management
New York
|
-$161M |
| 2 |
MAM
Melqart Asset Management
London,
United Kingdom
|
-$30.7M |
| 3 |
RA
Rovida Advisors
Fort Lauderdale,
Florida
|
-$22.8M |
| 4 |
TAL
TIG Advisors LLC
New York
|
-$21.2M |
| 5 |
Goldman Sachs
New York
|
-$18.6M |
